Ramy Fawzy Mahmoud  <br/><br/>
Dexmedetomidine as an Adjuvant to Bupivacaine in ultrasound-guided thoracic paravertebral block for breast cancer surgeries :   Efficacy of  two different doses /  
 استخدام عقار"الديكسميديتوميدين" كعقار مساعد ل"البوبيفاكين" في احصار جنبي الفقار الصدربأستخدام السونار في عمليات سرطان الثدي :    مقارنة بين جرعتين مختلفتين 
Ramy Fawzy Mahmoud ; Supervised Neamat Ibrahim , SaharAbdelhalim , Abeer Ahmed 
 - Cairo :   Ramy Fawzy Mahmoud ,   2015 
 - 78 Leaves :   charts , facsimiles ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anaesthesia 
<br/><br/> This study was conducted on 90 patients divided equally into 3 groups receiving  either dexmedetomidine 0.5 og/kg (groupBD0.5) or dexmedetomidine 1 og/kg  (groupBD1) added to Bupivacaine 0.25% or Bupivacaine 0.25% alone (group  B) in TPVB with general anaesthesia in females undergoing MRM.  Postoperative pain scores and opioid requirements were significantly lower in  the first 24 hours in both groups BD0.5 and group BD1       
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Breast Cancer   Dexmedetomidine  ETCO